Back to Insights

Virtual ISPOR Europe 2020

Congratulations to PRECISIONadvisors and PRECISIONheor for presenting more than a dozen posters and panels at Virtual ISPOR Europe 2020, 16 – 19 November, 2020.

See our full list of posters and panels below, and view on-demand sessions HERE!

HEOR:

Posters

  • Besada M, Lorenzi M, Tang D, Huey K, Schroeder T, Oliva EN
    • Systematic Literature Review Of Clinical Outcomes, Economic Burden, And Quality Of Life Burden Of Anemia In Elderly Patients
  • Besada M, Lorenzi M, Tang D, Huey K, Schroeder T, Oliva EN
    • Systematic Literature Review Of Clinical Outcomes, Economic Burden, And Quality Of Life Burden Of Anemia In Patients With Myelodysplastic Syndromes
  • Chew DS, Sacks N, Cyr PL, Everson KA, Wood DR, Pokorney SD
    • Trends In Diagnostic Testing Utilization And Expenditures In Patients With Newly Diagnosed Paroxysmal Supraventricular Tachycardia Patients In The United States 
  • Rehorn M, Sacks N, Emden MR, Healey B, Preib M, Cyr PL, Pokorney SD
    • Incidence and Prevalence of Supraventricular Tachycardia in the United States
  • Yoon Duk Hong, Lucinda Orsini, John Guerino, Marc Berger, Gail D. Betz, William Crown, Wim Goettsch, C. Daniel Mullins, Richard Willke, Jeroen P. Jansen.
    • Comparative effectiveness and safety of pharmaceuticals assessed in observational studies compared with randomized controlled trials

Panels

  • LIVE PRESENTATION — Kristian Kidholm, Jason Shafrin, Maja Kjaer Rasmussen, Hans Ossebaard
    • Will COVID-19 Accelerate the Adoption of Digital Health Technologies? Perspectives on Evaluating Digital Health Technologies during Global Disease Outbreaks  
  • ON-DEMAND — Howard Thom,  Sabine Grimm, Jeroen Jansen, Stephane Regnier.
    • Uncertainty and Healthcare Decision Making: A Dangerous Combination? 

ADVISORS:

Posters

  • Pinja Hartikainen, Kate Kolotorou, Navisha Doolub
    • Complex Innovative Design Trials: Too Complex for Market Access? 
  • Christina Poschen, Dominika Meszarosova, Navisha Doolub
    • Simple Discounts to Subscription-Based Models: What Is the Future of Multi-Indication Oncology Pricing and Access? 
  • Sabina Anwar, Laura Montani, Srishti Gupta
    • Dual-branding: A practical option to bolster patient access to novel medicines? 
  • Petra Ermacora, Dominika Meszarosova, Andrea Ong, David Carr
    • Innovative Approaches for Patient Access to Gene Therapies in Haemophilia
  • Dimitrios Tzaras, David Carr
    • Ensuring Patient Access to Gene Therapies: The Role of Companion Diagnostics 
2020-12-04T14:57:56-05:00